Relapse Analysis of Irradiated Patients Within the HD15 Trial of the German Hodgkin Study Group-Reference-Cited by-同舟云学术

Relapse Analysis of Irradiated Patients Within the HD15 Trial of the German Hodgkin Study Group

Published:2015-05 Issue:1 Volume:92 Page:46-53
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Kriz Jan,Reinartz Gabriele,Dietlein Markus,Kobe Carsten,Kuhnert Georg,Haverkamp Heinz,Haverkamp Uwe,Engenhart-Cabillic Rita,Herfarth Klaus,Lukas Peter,Schmidberger Heinz,Staar Susanne,Hegerfeld Kira^ORCID,Baues Christian,Engert Andreas,Eich Hans Theodor

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference22 articles.

1. Reduced treatment intensity in patients with early-stage Hodgkin’s lymphoma;Engert;N Engl J Med,2010

2. Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin’s lymphoma: Final analysis of the German Hodgkin Study Group HD11 trial;Eich;J Clin Oncol,2010

3. Modern radiation therapy for Hodgkin lymphoma: Field and dose guidelines from the International Lymphoma Radiation Oncology Group (ILROG);Specht;Int J Radiat Oncol Biol Phys,2014

4. Impact of adjuvant radiation on the patterns and rate of relapse in advanced-stage Hodgkin’s disease treated with alternating chemotherapy combinations;Yahalom;J Clin Oncol,1991

5. Randomized trial of chemotherapy versus chemotherapy plus radiotherapy for stage III-IV A & B Hodgkin’s disease;Pavlovsky;Ann Oncol,1992

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Classical Hodgkin Lymphoma: From Past to Future—A Comprehensive Review of Pathophysiology and Therapeutic Advances;International Journal of Molecular Sciences;2023-06-13

2. Radiation doses to mediastinal organs at risk in early-stage unfavorable Hodgkin lymphoma– a risk stratified analysis of the GHSG HD17 trial;Frontiers in Oncology;2023-05-05

3. Patterns of relapse and long-term outcome in patients treated with a curative intent for advanced Hodgkin lymphoma;Acta Oncologica;2022-09-02

4. Das Hodgkin-Lymphom in fortgeschrittenen Stadien;Die Onkologie;2022-06-01

5. High-risk stage IIB Hodgkin lymphoma treated in the H10 and AHL2011 trials: total metabolic tumor volume is a useful risk factor to stratify patients at baseline;Haematologica;2022-05-31